Parkinson's & Movement disorders

Gene therapy shown to remove core component of Parkinson's disease

An international team led by Rush researcher Jeffrey Kordower, Ph.D., has moved a step closer to developing a treatment to clear brain cells of a protein that is an integral cause of Parkinson's disease. The team published ...

Oncology & Cancer

Scientists identify weak point in deadly eye melanoma

A natural plant compound exploits a newly identified Achilles' heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma ...

Diseases, Conditions, Syndromes

Alpha-1 antitrypsin deficiency study released

Alpha-1 antitrypsin deficiency consists of a production deficit of a protein that protects the lungs from degradation or inflammation caused by lung infections, as well as from external agents such a tobacco or pollution. ...

Parkinson's & Movement disorders

Study identifies chaperone protein implicated in Parkinson's disease

Reduced levels of a chaperone protein might have implications for the development and progression of neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, according to new research from investigators ...

Parkinson's & Movement disorders

Study raises doubts on a previous theory of Parkinson's disease

Parkinson's disease was first described by a British doctor more than 200 years ago. The exact causes of this neurodegenerative disease are still unknown. In a study recently published in eLife, a team of researchers led ...

Neuroscience

Waves move across the human brain to support memory

The coordination of neural activity across widespread brain networks is essential for human cognition. Researchers have long assumed that oscillations in the brain, commonly measured for research purposes, brain-computer ...

page 18 from 33